Follow
Tom Snelling
Tom Snelling
Professor in Infectious Diseases, University of Sydney
Verified email at sydney.edu.au
Title
Cited by
Cited by
Year
Microbiome–host systems interactions: protective effects of propionate upon the blood–brain barrier
L Hoyles, T Snelling, UK Umlai, JK Nicholson, SR Carding, RC Glen, ...
Microbiome 6, 1-13, 2018
4252018
COVID-19 public health measures and respiratory syncytial virus
PN Britton, N Hu, G Saravanos, J Shrapnel, J Davis, T Snelling, ...
The Lancet Child & Adolescent Health 4 (11), e42-e43, 2020
1822020
Waning vaccine immunity in teenagers primed with whole cell and acellular pertussis vaccine: recent epidemiology
SL Sheridan, K Frith, TL Snelling, K Grimwood, PB McIntyre, SB Lambert
Expert review of vaccines 13 (9), 1081-1106, 2014
1232014
Case-control evaluation of the effectiveness of the G1P [8] human rotavirus vaccine during an outbreak of rotavirus G2P [4] infection in central Australia
TL Snelling, RM Andrews, CD Kirkwood, S Culvenor, JR Carapetis
Clinical Infectious Diseases 52 (2), 191-199, 2011
1152011
Parental Tdap boosters and infant pertussis: a case-control study
HE Quinn, TL Snelling, A Habig, C Chiu, PJ Spokes, PB McIntyre
Pediatrics 134 (4), 713-720, 2014
1102014
Choosing primary endpoints for clinical trials of health care interventions
C McLeod, R Norman, E Litton, BR Saville, S Webb, TL Snelling
Contemporary clinical trials communications 16, 100486, 2019
1072019
Neurologic complications of influenza A (H1N1) pdm09: surveillance in 6 pediatric hospitals
G Khandaker, Y Zurynski, J Buttery, H Marshall, PC Richmond, RC Dale, ...
Neurology 79 (14), 1474-1481, 2012
1062012
Duration of protection after first dose of acellular pertussis vaccine in infants
HE Quinn, TL Snelling, KK Macartney, PB McIntyre
Pediatrics 133 (3), e513-e519, 2014
1052014
Effectiveness of palivizumab in preventing RSV hospitalization in high risk children: a real‐world perspective
N Homaira, W Rawlinson, TL Snelling, A Jaffe
International journal of pediatrics 2014 (1), 571609, 2014
1042014
Combination of clinical symptoms and blood biomarkers can improve discrimination between bacterial or viral community-acquired pneumonia in children
MU Bhuiyan, CC Blyth, R West, J Lang, T Rahman, C Granland, C de Gier, ...
BMC pulmonary medicine 19, 1-9, 2019
1032019
‘Hesitant compliers’: Qualitative analysis of concerned fully-vaccinating parents
SL Enkel, K Attwell, TL Snelling, HE Christian
Vaccine 36 (44), 6459-6463, 2018
992018
Influenza epidemiology, vaccine coverage and vaccine effectiveness in children admitted to sentinel Australian hospitals in 2014: the Influenza Complications Alert Network (FluCAN)
CC Blyth, KK Macartney, S Hewagama, S Senenayake, ND Friedman, ...
Eurosurveillance 21 (30), 30301, 2016
902016
Rotavirus and the indigenous children of the Australian outback: monovalent vaccine effective in a high-burden setting
TL Snelling, R Schultz, J Graham, R Roseby, GL Barnes, RM Andrews, ...
Clinical infectious diseases 49 (3), 428-431, 2009
802009
The contribution of viruses and bacteria to community-acquired pneumonia in vaccinated children: a case–control study
MU Bhuiyan, TL Snelling, R West, J Lang, T Rahman, C Granland, ...
Thorax 74 (3), 261-269, 2019
782019
Regulation of blood–brain barrier integrity by microbiome-associated methylamines and cognition by trimethylamine N-oxide
L Hoyles, MG Pontifex, I Rodriguez-Ramiro, MA Anis-Alavi, KS Jelane, ...
Microbiome 9, 1-21, 2021
772021
Geographic variation in the eukaryotic virome of human diarrhea
LR Holtz, S Cao, G Zhao, IK Bauer, DM Denno, EJ Klein, M Antonio, ...
Virology 468, 556-564, 2014
772014
High burden of RSV hospitalization in very young children: a data linkage study
N Homaira, JL Oei, KA Mallitt, ME Abdel-Latif, L Hilder, B Bajuk, K Lui, ...
Epidemiology & Infection 144 (8), 1612-1621, 2016
692016
Association between convalescent plasma treatment and mortality in COVID-19: a collaborative systematic review and meta-analysis of randomized clinical trials
C Axfors, P Janiaud, AM Schmitt, J van’t Hooft, ER Smith, NA Haber, ...
BMC infectious diseases 21, 1-23, 2021
622021
Core outcomes set for trials in people with coronavirus disease 2019
A Tong, JH Elliott, LC Azevedo, A Baumgart, A Bersten, L Cervantes, ...
Critical care medicine 48 (11), 1622-1635, 2020
612020
Management of invasive group A streptococcal infections
CS Waddington, TL Snelling, JR Carapetis
Journal of Infection 69, S63-S69, 2014
612014
The system can't perform the operation now. Try again later.
Articles 1–20